Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

OBJECTIVE Previous studies have suggested that there may be an association between longer duration of untreated psychosis and poor outcome in schizophrenia. These studies have been interpreted as providing evidence that untreated psychosis may constitute an "active morbid process" that is "toxic" to the brain. If untreated psychosis is neurotoxic, this would form a strong basis for early intervention in schizophrenia. METHOD Seventy-four neuroleptic-naive patients with DSM-IV schizophrenia were evaluated 6 months after their first inpatient hospitalization. The authors examined the relationship between untreated initial psychosis duration (measured from onset of first symptom as well as from onset of full positive syndrome) and quality of life, symptom severity, and time to remission of positive symptoms. RESULTS Earlier age at illness onset was associated with longer duration of untreated prodromal psychotic symptoms. There were no significant gender differences in duration of untreated initial psychosis, nor were there any significant associations between untreated initial psychosis duration and premorbid functioning. After controlling for the effects of age at onset, the duration of untreated initial psychosis did not significantly impair subsequent quality of life, symptom severity, or remission of positive symptoms. CONCLUSIONS Duration of untreated initial psychosis was not prognostic of poor outcome early in the course of schizophrenia. Biological measures of neurotoxicity are needed to examine the "toxic psychosis" hypothesis more directly.

[1]  J. Waddington,et al.  Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia , 1997, Psychological Medicine.

[2]  J. Lieberman,et al.  Duration of psychosis and outcome in first-episode schizophrenia. , 1992, The American journal of psychiatry.

[3]  W T Carpenter,et al.  The prediction of outcome in schizophrenia. I. Characteristics of outcome. , 1972, Archives of general psychiatry.

[4]  W. Eaton,et al.  Outcome of Schizophrenia: The Madras Longitudinal Study , 1996, The Australian and New Zealand journal of psychiatry.

[5]  T. Nakajima,et al.  A Longitudinal Study of Schizophrenia in Adolescence: I. The One‐ to Three‐Year Outcome , 1986, The Japanese journal of psychiatry and neurology.

[6]  J. Waddington,et al.  Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia , 1995, Psychological Medicine.

[7]  W. Dixon,et al.  Schizophrenia--a follow-up study of results of treatment. , 1976, Archives of general psychiatry.

[8]  J. Lindenmayer,et al.  Outcome Predictors in Acute Schizophrenia: Prospective Significance of Background and Clinical Dimensions , 1987, The Journal of nervous and mental disease.

[9]  R. Bilder,et al.  Symptomatic and neuropsychological components of defect states. , 1985, Schizophrenia bulletin.

[10]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[11]  C. Mihalopoulos,et al.  EPPIC: an evolving system of early detection and optimal management. , 1996, Schizophrenia bulletin.

[12]  J. Rabinowitz,et al.  Relationship between type of insurance and care during the early course of psychosis. , 1998, The American journal of psychiatry.

[13]  A. Korten,et al.  “Mental health literacy”: a survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment , 1997, The Medical journal of Australia.

[14]  W. Lo,et al.  A Ten-Year Follow-up Study of Chinese Schizophrenics in Hong Kong , 1977, British Journal of Psychiatry.

[15]  R J Wyatt,et al.  Neuroleptics and the natural course of schizophrenia. , 1991, Schizophrenia bulletin.

[16]  T. Crow,et al.  II. A Randomised Controlled Trial of Prophylactic Neuroleptic Treatment , 1986, British Journal of Psychiatry.

[17]  H. Blum,et al.  Five-year Outcome and Prognosis in Schizophrenia: A Report from the London Field Research Centre of the International Pilot Study of Schizophrenia , 1987, British Journal of Psychiatry.

[18]  N. Andreasen,et al.  Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia , 1993, Schizophrenia Research.

[19]  F. Sainfort,et al.  Judgments of quality of life of individuals with severe mental disorders: Patient self-report versus provider perspectives. , 1996, The American journal of psychiatry.

[20]  J. McEvoy,et al.  Predictors of therapeutic response to haloperidol in acute schizophrenia. , 1991, Psychopharmacology bulletin.

[21]  N C Andreasen,et al.  Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. , 1998, The American journal of psychiatry.

[22]  J. O. Johannessen,et al.  Early detection and intervention with schizophrenia: rationale. , 1996, Schizophrenia bulletin.

[23]  H. Hwu,et al.  Negative Symptoms at Discharge and Outcome in Schizophrenia , 1995, British Journal of Psychiatry.

[24]  M. Angermeyer,et al.  Relatives' beliefs about the causes of schizophrenia , 1996, Acta psychiatrica Scandinavica.

[25]  P. May,et al.  Treatment of Schizophrenia , 1965, British Journal of Psychiatry.

[26]  Alogia, attentional impairment, and inappropriate affect: Their status in the dimensions of schizophrenia , 1993 .

[27]  T. McGlashan,et al.  Sustained remission in drug-free schizophrenic patients. , 1987, The American journal of psychiatry.

[28]  E. Lindström,et al.  Symptoms at index admission as predictor for 1‐5 year outcome in schizophrenia , 1996, Acta psychiatrica Scandinavica.

[29]  J. Goldstein Gender differences in the course of schizophrenia. , 1988, The American journal of psychiatry.

[30]  A. Riecher-Rössler,et al.  The Influence of Age and Sex on the Onset and Early Course of Schizophrenia , 1993, British Journal of Psychiatry.

[31]  H. Möller,et al.  Outcome in schizophrenic and similar paranoid psychoses. , 1982, Schizophrenia bulletin.

[32]  J. Waddington,et al.  Untreated psychosis and long-term outcome in schizophrenia. , 1998, Schizophrenia bulletin.

[33]  Anthony F Jorm,et al.  Mental health literacy , 2000, British Journal of Psychiatry.

[34]  R. Wyatt,et al.  Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data , 1997, Psychological Medicine.

[35]  Tyrone D. Cannon,et al.  Course of treatment response in first-episode and chronic schizophrenia. , 1996, The American journal of psychiatry.

[36]  C. Frith,et al.  The Outcome of Severe Acute Schizophrenic Illnesses After One Year , 1979, British Journal of Psychiatry.

[37]  J. Strauss,et al.  Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. , 1977, Archives of general psychiatry.

[38]  R. Wyatt The Dopamine Hypothesis: Variations on a Theme , 1985 .

[39]  N. Andreasen,et al.  The Iowa prospective longitudinal study of recent-onset psychoses. , 1992, Schizophrenia bulletin.

[40]  D. Pickar,et al.  National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. , 1991, Archives of general psychiatry.

[41]  W. Carpenter Medication-Free Research and Patient Safety , 1998 .

[42]  J. Lieberman,et al.  Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. , 1995, The American journal of psychiatry.

[43]  P. Liddle The Symptoms of Chronic Schizophrenia , 1987, British Journal of Psychiatry.

[44]  W. Dixon,et al.  Schizophrenia--a follow-up study of results of treatment. I. Design and other problems. , 1976, Archives of general psychiatry.

[45]  W. Carpenter The risk of medication-free research. , 1997, Schizophrenia bulletin.

[46]  J. Schwartz,et al.  The natural course of schizophrenia: a review of first-admission studies. , 1992, Schizophrenia bulletin.

[47]  N C Andreasen,et al.  The Distinction of Positive and Negative Symptoms , 1991, British Journal of Psychiatry.

[48]  J. Addington,et al.  Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. , 1993, Journal of psychiatry & neuroscience : JPN.

[49]  J. Bailer,et al.  Premorbid adjustment as predictor of outcome in schizophrenia: results of a prospective study , 1996, Acta psychiatrica Scandinavica.

[50]  J. Kane,et al.  Outcome study of first-episode psychosis. I: Relapse rates after 1 year. , 1986, The American journal of psychiatry.

[51]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[52]  W. Dixon,et al.  Schizophrenia. A follow-up study of the results of five forms of treatment. , 1981, Archives of general psychiatry.

[53]  L. Linn,et al.  Chronic mental patients: the quality of life issue. , 1982, The American journal of psychiatry.

[54]  E. Bromet,et al.  The Suffolk County Mental Health Project: demographic, pre-morbid and clinical correlates of 6-month outcome , 1996, Psychological Medicine.

[55]  A. Awad Quality of life rediscovered: implications for clinical outcome and health economics in schizophrenia. , 1997, Journal of psychiatry & neuroscience : JPN.

[56]  R. Wyatt Early intervention for schizophrenia: Can the course of the illness be altered? , 1995, Biological Psychiatry.